Abstract Elevated glutamate levels have been reported in humans with diabetic retinopathy. Retinal Müller glial cells regulate glutamate levels via the GLAST transporter and system x c − (cystine-glutamate exchanger). We have investigated whether transporter function and gene and/or protein expression are altered in mouse Müller cells cultured under conditions of hyperglycemia or oxidative stress (two factors implicated in diabetic retinopathy). Cells were subjected to hyperglycemic conditions (35 mM glucose) over an 8-day period or to oxidative stress conditions (induced by exposure to various concentrations of xanthine:xanthine oxidase) for 6 h. The Na +
Introduction
Müller cells, the predominant retinal glial cell type, are essential for maintaining homeostasis in the extracellular milieu. They provide physical and metabolic support for retinal neurons by regulating the transport and metabolism of neurotransmitters. Glutamate is the major retinal excitatory neurotransmitter for the photoreceptor-bipolar-ganglion cell circuit. It is normally found at high levels within neurons but is maintained at low concentrations extracellularly minimizing excitotoxicity. The disruption of glutamate homeostasis has been reported in diabetic retinopathy (Pulido et al. 2007 ). Human diabetic patients have an elevated vitreal glutamate concentration of~25 μM compared with~9 μM in non-diabetic individuals (Ambati et al. 1997) . Increased glutamate levels have been reported in the retinas of diabetic rats (Lieth et al. 1998; Kowluru et al. 2001) . Given that extracellular glutamate is toxic to neurons (Goto et al. 2002; Otori et al. 1998; Vorwerk et al. 1996) , and that neuronal death is a feature of diabetic retinopathy (Abu El-Asrar et al. 2004; Barber et al. 1998; Martin et al. 2004; Barber 2003; Barber et al. 2005; Smith et al. 2008) , an analysis of the mechanism responsible for the accumulation of glutamate might be relevant to the pathogenesis of diabetic retinopathy.
In the retina, the main glutamate transporter expressed by Müller cells is GLAST (Kanai and Hediger 2004; Rauen et al. 1996) . GLAST (also known as EAAT1) is one of five sodiumdependent electrogenic high-affinity excitatory amino-acid transporters (EAAT1-5) present in the retina. The powerful GLAST transporter can concentrate glutamate 10,000-fold inside the cell relative to the low extracellular concentration of glutamate (~1 μM) (Rauen et al. 1998) . Retinal glutamate levels can also be regulated by system x c − , a Na + -independent electroneutral cystine-glutamate exchanger that is expressed in Müller cells and in ganglion and retinal pigment epithelial (RPE) cells (Bridges et al. 2001 (Bridges et al. , 2004 Dun et al. 2006; Kato et al. 1993) . System x c − is composed of two subunits: the transport specific xCT subunit and the ubiquitous 4F2hc subunit (Sato et al. 1999) . The stoichiometry of this obligatory exchanger is 1:1; the direction of transport is driven by the concentration gradient of the substrate (Bannai and Kitamura 1980) . Under physiological conditions, system x c − transports cystine into the cell coupled to the efflux of glutamate out of the cell (McBean 2002) . Once inside the cell, cystine is converted to cysteine, the rate-limiting factor in the production of the antioxidant tripeptide glutathione. Hyperglycemia and oxidative stress are major factors that have been implicated in the pathogenesis of diabetic retinopathy. Hyperglycemia is considered the single most important factor in the onset and progression of this disease (Genuth 2006) . Oxidative stress is associated with the severity and duration of diabetic retinopathy in human and animal models (Gürler et al. 2000; Kowluru and Chan 2007; Van Reyk et al. 2003) . Although the function of system x c − has not been analyzed in diabetic retinopathy, the function of GLAST has been studied in models of this disease. Li and Puro (2002) have used freshly dissociated Müller cells from streptozotocin-induced diabetic rats and assessed transporter function electrophysiologically by measuring inward current induced by 1-trans-pyrrolidine-2, 4-dicarboxylate (PDC); they have reported a 67% decrease in transporter activity, which they attribute largely to oxidative stress. Ward and co-workers have analyzed GLAST expression levels in intact streptozotocin-induced diabetic rat retinas and found no significant change in GLAST expression as compared with control retinas (Ward et al. 2005) . They have also injected D-aspartate, a nonmetabolizable substrate for GLAST, intravitreally and examined the level of D-aspartate uptake in fixed retinal tissue by subjecting the specimen to immunodetection with an antibody against D-aspartate; they have reported that, in the diabetic retina, D-aspartate uptake is actually enhanced not reduced and concluded that Müller cells maintain GLAST function in diabetes (at least during early stages). These conflicting findings are intriguing and have prompted us to exploit a methodology that is wellestablished in our laboratory, whereby the activity of various transporter proteins can be determined directly by measuring the uptake of radiolabeled substrates in cultured cells (Bridges et al. 2001; Dun et al. 2006 ). The method is especially enlightening when the influence of a single parameter on transporter activity is to be analyzed. In the present study, we have used Müller cells isolated from the mouse retina to evaluate the effects specifically of hyperglycemia on radiolabeled glutamate uptake as a reflection of GLAST and system x c − transporter activity. In subsequent independent experiments, we have analyzed the effects of oxidative stress on the function of these two glutamate transporter systems. Our findings suggest that short-term hyperglycemia does not alter the activity of GLAST or system x c − , although it does lead to increased protein levels after longer hyperglycemic exposure. Much more striking are the effects of oxidative stress, with the most pronounced effect being a marked increase in the activity of system x c − and expression of xCT.
Materials and methods

Isolation of mouse Müller cells
C57BL/6 mouse breeding pairs were obtained from Harlan Sprague Dawley (Indianapolis, Ind., USA). They were maintained in the animal facilities of the Medical College of Georgia according to institutional policy for the appropriate care and use of animals in research. Müller cells were isolated from 6-to 7-day-old mice following our published method (Jiang et al. 2006; Umapathy et al. 2005) . Growth medium consisting of 10% fetal bovine serum (FBS), 1% penicillin-streptomycin in low glucose (5.5 mM) DMEM with pyruvate, was changed every 1-2 days, and Müller cells were passaged every 4-7 days. After 3-5 passages, cells were frozen at -80°C until used.
Immunocytochemistry
Culture purity was verified periodically with each passage and after freezing and thawing as previously described (Jiang et al. 2006) . Briefly, a panel that included antibodies against vimentin, glutamine synthetase (GS), cellular retinaldehyde-binding protein (CRALBP), glial acid fibrillary protein (GFAP), cytokeratin 8, and NF-L was used. The cells were positive for vimentin and GS (known markers of Müller cells in vivo) and for CRALBP (a marker for Müller and RPE cells). There was minimal staining for GFAP (a marker for astrocytes and for Müller cells under distress). The cells were negative for cytokeratin 8 (expressed by RPE cells) and for the neuronal marker NF-L. To verify the presence of GLAST, xCT, and 4F2hc, Müller cells were seeded onto coverslips. The next day, they were fixed in 4% paraformaldehyde for 10 min, permeabilized for 5 min in 0.25% Triton X-100, incubated with Power Block for 1 h, and then exposed to primary antibody for 3 h at room temperature. The following antibodies were purchased: guinea pig anti-GLAST, goat anti-vimentin (Chemicon, Billerica, Mass.); Alexa Fluor 488 donkey anti-goat (Invitrogen, Carlsbad, Calif.); CY3-conjugated donkey anti-goat, CY3-conjugated donkey antiguinea pig, CY3-conjugated donkey anti-rabbit (Jackson Immunologicals, West Grove, Pa.); rabbit anti-EAAT1, goat anti-CD98 (4F2hc), and horseradish peroxidase (HRP)-conjugated goat anti-mouse, goat anti-rabbit, and mouse anti-goat (Santa Cruz Biotechnology, Santa Cruz, Calif.). The preparation of the anti-xCT antibody was as described by Dun et al. (2006) . Cells were washed and reblocked with FX signal enhancer for 30 min followed by either CY3 (1:500) or Alexa Fluor 488 (1:1,000) for 1 h at room temperature. After the preparations had been washed, nuclei were counterstained with Hoechst dye 33342 (1:10,000). Coverslips were mounted on slides with aqueous gel mount, and the cells were visualized by using a Zeiss Axioplan-2 microscope equipped with the axiovision program and an HRM camera.
Müller cell treatment
Cells were thawed and grown in culture flasks with a change of media every 1-2 days. After 4 days, cells were passaged and seeded for experiments. For transporter assays, 1 ml growth medium containing 100,000 cells/ml was added to each well of a 24-well plate. For gene and protein expression studies, cells were plated such that the ratio of cell number and media volume per square centimeter of growth area was the same as that for transport assays. Medium was refreshed every 1-2 days. After 4 days, the medium was changed to low serum medium (0.5% FBS in low glucose DMEM). The next day treatment began. For hyperglycemia experiments, the concentration of D-glucose in the medium (DMEM 11966; Invitrogen) was adjusted to either 5 mM or 35 mM. Osmolar controls for these experiments included the incubation of cells under hyperosmolar conditions (5 mM glucose plus 30 mM mannitol, L-glucose, and sorbitol). For oxidative stress experiments, treatment solutions were prepared in base medium containing 5 mM glucose and 0.5% FBS in "no-glucose" DMEM 11966. Solutions containing 20 μM, 80 μM, 140 μM, and 200 μM xanthine were prepared from 0.2 M xanthine stock solution prepared in 1 N NaOH. Corresponding xanthine control solutions were prepared with vehicle (1 N NaOH) alone. Xanthine oxidase solutions were prepared in base media and contained 4 mU/ml, 16 mU/ml, 28 mU/ml, and 40 mU/ml xanthine oxidase. At the time of treatment, medium was discarded, and equal volumes of xanthine and xanthine oxidase solutions were applied directly to the cells to form the final 1× treatment solutions of 10:2, 40:8, 70:14, and 100:20 (expressed as micromolar xanthine:milliunits per milliliter xanthine oxidase). All treatment solutions were prepared fresh before treatment.
Functional assay to determine transport activity of GLAST and system x c − Uptake of glutamate by the Na + -dependent GLAST transporter and Na + -independent system x c − was performed in parallel experiments in which the uptake buffer either contained Na + (25 mM HEPES/TRIS, 140 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl 2 , 0.8 mM MgSO 4 , and 5 mM glucose, pH 7.5) or did not, in which case, NaCl was replaced by 140 mM N-methyl-D-glucamine chloride.
System x c − is a freely reversible exchanger for cystine/ glutamate; one can study the transport function either by monitoring the influx of radiolabeled cystine in exchange for the efflux of cellular glutamate or by monitoring the influx of radiolabeled glutamate in exchange for the efflux of cellular glutamate (since system x c − can also function as a Na + -independent glutamate/glutamate exchanger). However, once inside the cell, the cystine is converted to cysteine, which is not transported by system x c − . The intracellular level of cystine is necessarily low and hence would not be an easily measured substrate for the transporter. The most accurate method to study the transporter function is to measure influx of [ 3 H]-labeled substrate, rather than the highly unstable [ 35 S]-labeled cystine. Even though Na+-independent glutamate uptake can occur via AGT1, there is no evidence for expression of this transporter in the retina (Sarthy et al. 2005) , and thus Na + -independent uptake of glutamate in Müller cells represents the function of system x c − exclusively (Bridges et al. 2001 ). L-[G-3 H]-glutamic acid (specific radioactivity: 43.0 Ci/ mmol, concentration: 1.0 mCi/ml; Amersham Bioscience, Arlington Heights, Ill.) was used as the substrate for uptake experiments. Uptake was initiated by the addition of 250 µl uptake buffer containing 2.5 μM glutamate spiked with 2.0 μCi/ml radiolabeled [ 3 H]-glutamate. Cells were incubated for 15 min at 37°C, after which time, the buffer was removed, and the cells were washed twice with ice-cold uptake buffer. The cells were then solubilized with 0.5 ml 1% SDS, 0.2 N NaOH, and radioactivity was determined by liquid scintillation spectrometry. Protein was measured by using the Bio-Rad protein assay reagent.
Glutamate uptake in the presence of Na + reflects the activity of both Na + -dependent GLAST and Na + -independent system x c − . Glutamate uptake by GLAST was determined by calculating the glutamate uptake in the presence of Na + and subtracting the uptake in the absence of Na + . The uptake by system x c − was calculated directly from the radioactivity data for glutamate uptake in the absence of Na + .
GLAST and system x c − kinetics
Kinetic analyses of GLAST and system x c − activities were performed in Müller cells treated for 6 h in the presence or absence of 70 μM xanthine:14 mU/ml xanthine oxidase. GLAST and system x c − activities were assessed by using increasing amounts of cold glutamate ranging from 2.5 μM to 500 μM. 
Western blot analysis
Cells were washed in buffer containing 0.32 M mannitol, 1.0 mM EDTA disodium salt, pH 7.4 with Complete Mini Protease Inhibitor Cocktail tablets (Roche Diagnostics, Indianapolis, Ind.) and 50 mM dithiothreitol (DTT). To detect GLAST, samples containing 30 μg protein were suspended in sucrose loading buffer at a final buffer concentration of 70 mM SDS, 62.5 mM TRIS-HCl, 0.3 M sucrose, 50 mM DTT, pH 6.8, plus 10 μg/ml bromophenol blue. To detect xCT and 4F2hc, samples containing 30 μg were prepared in Bio-Rad Laemmli buffer (62.5 mM TRISHCl, pH 6.8, 2% SDS, 25% glycerol, 0.01% bromophenol blue) with β-mercaptoethanol. Samples were loaded onto 8% polyacrylamide gels and electrophoresed in TRISglycine running buffer (25 mM TRIS, 250 mM glycine, 10% SDS, pH 8.3). The separated proteins were transferred to nitrocellulose membranes in cold transfer buffer (48 mM TRIS, 39 mM glycine, 0.4% SDS, 20% methanol, pH 8.3). Membranes were rinsed in distilled H 2 O and stained with 0.1% Ponceau solution (5% glacial acetic acid, 95% distilled H 2 O, 0.1% Ponceau). All washes and blocking solutions consisted of TBST (0.05 M TRIS HCl, 0.15 M NaCl, 0.5% Tween-20, pH 7.4). Membranes were blocked for 15 min in 5% non-fat milk solution and incubated with the appropriate antibody diluted in milk solution overnight at 4˚C, except for β-actin, the preparation for which was incubated for 3 h at room temperature. The antibody dilutions used were as follows: rabbit anti-GLAST, 1:200 in 5% milk; rabbit anti-xCT, 1:500 in 1% milk; goat anti-CD98 (4F2hc), 1:1,000 in 1% milk; mouse monoclonal β-actin, 1:5,000 in 5% milk. After being probed with primary antibody, membranes were rinsed with TBST and re-probed with the appropriate HRP-conjugated secondary. Membranes were incubated in SuperSignal West Pico Chemiluminescent substrate (Pierce Biotechnology, Rockford, Ill.). Films, to which membranes were exposed, were scanned into Adobe Photoshop Adobe Photoshop Version 9.0 (Adobe Systems, San Jose, Calif.). A drag-and-drop rectangular grid was placed over the band of interest, and the histogram feature was used to determine band density corrected for background.
Biotinylation of plasma membrane proteins
Biotinylation of plasma membrane proteins was performed by using the Pinpoint Cell Surface Protein Isolation Kit (Pierce Biotechnology) according to the manufacturer's instructions. Briefly, the surface of intact cells was labeled with a thiol-cleavable amine-reactive biotinylation reagent. Cells were lysed in mild detergent, and the labeled membrane proteins were collected by means of a column containing Immobilized NeutrAvidin Gel (Pierce Biotechnology). The column eluate contained the intracellular protein fraction. Membrane proteins were released by incubating the column with SDS-polyacrylamide gel sample buffer containing 50 mM DTT. After separation of the plasma membrane and intracellular fraction, protein content was determined by using the Bio-Rad RC DC protein assay. Samples were stored at -80°until analysis by Western blot.
Semi-quantitative polymerase chain reaction
The RNeasy mini kit (Qiagen, Germantown, Md.) was used to collect RNA from Müller cells. Cell lysates were homogenized by using a QIAshredder spin column (Qiagen), and RNA was collected according to the manufacturer's instructions. Total RNA was converted to cDNA by using the GeneAmp RNA PCR kit (Applied Biosystems, Foster City, Calif.). The polymerase chain reaction (PCR) was performed with the Takara Taq DNA polymerase kit (Takara Bio USA, Madison, Wis.) with primer pairs for GLAST, xCT, or 4F2hc in combination with a primer competimer pair for 18S as an internal control. The cycle numbers for quantification of each product were chosen in the linear range of the PCR. The 18S primer competimer ratios were optimized so that the intensity of the 18S band (315 bp) was similar in intensity to the product of interest. The PCR products were electrophoresed on a 2% agarose gel containing 1:8,000 SYBRsafe DNA gel stain and visualized under UV light. A photograph of the gel was imported into Adobe Photoshop. A drag-and-drop rectangular grid was placed over the band of interest. The histogram feature was used to determine band density corrected for background.
For GLAST, the upstream primer 5′-TCAATGCCCTGG GCCTAGTTGT-3′ (sense) and the downstream primer 5′-GGGTGGCAGAACTTGAGGAGG-3′ (antisense) form a 384-bp product and correspond to nucleotide positions 1211-1232 and 1594-1574, respectively, in mouse (NM 148938.2). The 18S primer competimer ratio was 5:5. PCR was performed for 26 cycles with a denaturing phase of 30 s at 95°C, an annealing phase of 30 s at 65°C, and an extension phase of 30 s at 72°C. The xCT upstream primer 5′-CCTGGCATTTGGACGCTACAT-3' (sense) and the downstream primer 5′-TGAGAATTGCTGTGAGCTTGCA-3′ (antisense) form a 182-bp product and correspond to nucleotide positions 781-801 and 962-941, respectively, in mouse (NM 011990.2). The 18S primer competimer ratio was 1.5:8.5. PCR was performed for 30 cycles with a denaturing phase of 30 s at 95°C, an annealing phase of 30 s at 60°C, and an extension phase of 30 s at 72°C. The 4F2hc upstream primer 5′-CTCCCAGGAAGATTTTAAAG ACCTTCT-3′ (sense) and the downstream primer 5′-TTCATTTTGGTGGCTACAATGTCAG-3′ (antisense) form a 141-bp product and correspond to nucleotide positions 661-687 and 801-777, respectively, in mouse (NM 008577.3). The 18S primer competimer ratio was 3.5:6.5. PCR was performed for 30 cycles with a denaturing phase of 30 s at 95°C, an annealing phase of 30 s at 60°C, and an extension phase of 30 s at 72°C.
Statistical analysis
The Excel data analysis tool (Microsoft Excel 2002, Microsoft, Redmond, Wash.) was used to make pairwise comparisons between treatments and controls. For multiple comparisons, the Mini Tab Minitab 15.0 program (Minitab, State College, Pa.) was employed to perform the Bonferroni pairwise comparison with a control. A P-value of <0.05 was considered significant.
Results
Immunocytological experiments performed in mouse Müller cells detected GLAST and both components of system x c − (xCT and 4F2hc), as shown in Fig. 1 : GLAST (Fig. 1a) , xCT (Fig. 1b) , and 4F2hc subunit (Fig. 1c) . The merged images of xCT and 4F2hc showed the many areas of colocalization of xCT and 4F2hc (Fig. 1d) .
4F2hc is a protein that can work in conjunction with many transporter proteins in addition to xCT. Some of these proteins are located within the cell cytoplasm and adjacent to the nucleus.
As anticipated, the cells were positive for vimentin, a marker for Müller cells (Fig. 1e) , and for other Müller cell markers but were negative for proteins found solely in RPE or neurons (data not shown). Incubation of cultures with Fig. 1 Immunodetection of GLAST, system x c − (xCT and 4F2hc components), and vimentin in mouse Müller cells. a Anti-GLAST antibody (1:500) followed by Cy-3 (red) secondary antibody (1:500). b Anti-xCT antibody (1:200) followed by Cy-3 (red) secondary antibody (1:500). c Anti-4F2hc antibody (1:200) followed by Alexa-488 (green) secondary antibody (1:1,000). d Merged image of xCT (red) and 4F2hc (green). Co-localization of xCT and 4F2hc appears orange-yellow. e Anti-vimentin antibody (1:500) followed by Cy-3 (red) secondary antibody (1:500). f Typical negative control with antibody preadsorbed with blocking peptide. Nuclei were stained blue with Hoechst 33342 (1:10,000). Bars20 μm antibody preadsorbed with the appropriate blocking peptide yielded no positive immunofluorescence (Fig. 1f) . These data suggest that mouse Müller cells are appropriate for studies of GLAST and system x c − activity.
Uptake of radiolabeled-glutamate by GLAST and system x c − was measured in Müller cells exposed to 35 mM glucose compared with physiological glucose levels (5 mM). Glucose at 35 mM reflects a severe hyperglycemic state equivalent to 637 mg/dl glucose; such glucose levels have been reported in mouse models of diabetes (Martin et al. 2004; Barber et al. 2005; Smith et al. 2008) . Cells were exposed to 35 mM glucose for 15 min, 6 h, or 1, 2, 4, or 8 days. Data are presented as the percentage of control uptake (100% for cells in 5 mM glucose) and show that exposure of cells to 35 mM glucose does not alter GLAST activity relative to controls for either shorter incubation times (15 min, 6 h, 1 day) or extended periods (2, 4, or 8 days; Fig. 2a) . Similarly, system x c − transporter activity did not differ in cells exposed to 35 mM glucose compared with controls for any of the treatment times tested (Fig. 2b) .
Given that elevated glucose levels are associated with hyperosmolarity, the experiments were also performed with medium containing 5 mM glucose and 30 mM of an osmolyte (mannitol, L-glucose, or sorbitol) for the same time period (15 min to 8 days). None of the osmolytes tested showed any osmolar effect on GLAST or system x c − transporter activity (data not shown). The finding that hyperglycemia did not alter the function of GLAST or system x c − was unexpected and prompted a comprehensive analysis of the effect of hyperglycemia on GLAST and system x c − gene and protein expression. Gene expression levels for GLAST, xCT and 4F2hc were unchanged for the hyperglycemic conditions (data not shown). There was a slight increase in the protein levels for GLAST and xCT when Müller cells were exposed for 8 days to 35 mM glucose (Fig. 3) . These data suggest that factors other than hyperglycemia, but which are associated with diabetes, contribute to the observed changes in GLAST activity reported by Li and Puro (2002) and Ward et al. (2005) . Oxidative stress is a major factor associated with diabetes; hyperglycemiainduced overproduction of superoxide by the electron transport chain is involved in the pathogenesis of diabetes (Nishikawa et al. 2000) . Oxidative stress was induced in Müller cell cultures using a combined application of xanthine:xanthine oxidase at increasing concentrations, and the effects on the uptake of glutamate by GLAST or system x c − were assessed. Exposure of cells for as short a time period of 6 h to increasing levels of oxidative stress (xanthine:xanthine oxidase ratios of 70:14 and 100:20) decreased GLAST transporter activity by~10% (Fig. 4a) , indicating that GLAST function was sensitive to this diabetes-associated factor. Oxidative stress had the opposite effect on system x c − and increased the transporter activity markedly. A 6-h treatment with 40:8, 70:14, and 100:20 xanthine:xanthine oxidase concentrations increased system x c − activity by 14%, 43%, and 89%, respectively (Fig. 4b) .
Exposure of cells to higher xanthine:xanthine oxidase concentrations (200:40) led to cell death (data not shown). Kinetic analyses of GLAST and system x c − transporter activities were performed in Müller cells treated with 70:14 xanthine:xanthine oxidase for 6 h. The uptake of radiolabeled glutamate by GLAST and system x c − by cells was measured by using increasing amounts of non-radioactive glutamate. The concentrations used were 2.5, 25, 125, 250, and 500 μM and 5, 10 mM glutamate. Non-radioactive 5 and 10 mM glutamate was used to determine the noncarrier-mediated diffusional component, these concentrations representing 20-40 times the reported K t value for the transporter (Bridges et al. 2001 ). This diffusional component was subtracted from total uptake values in the kinetic analysis. The uptake of glutamate by GLAST and system x c − was plotted as a function of glutamate concentration Fig. 2 Effect of hyperglycemia on GLAST and system x c − activity. Mouse Müller cells were exposed to 35 mM (hyperglycemic) or 5 mM (normoglycemic) conditions for 15 min, 6 h, or 1, 2, 4, or 8 days. GLAST (a) and system x c − (b) transporter activities were assessed after each treatment time. Transporter activities for cells treated with 35 mM glucose were expressed relative to 5 mM controls (100%). No differences in transporter activities were detected for cells treated with 35 mM glucose compared with 5 mM glucose at any of the times tested. Values are means±SE from two to three independent experiments performed in triplicate (Fig. 5) . The inset graphs in Fig. 5a , b are the Eadie-Hofstee plots of transporter activity (V) versus transporter activity divided by glutamate concentration (V/S). For data that follow Michaelis-Menten kinetics, the Eadie-Hofstee plot produces a line with a slope equal to -K m , and a y intercept equal to V max . The kinetic analysis showed that the xanthine:xanthine-oxidase-induced decrease in GLAST activity was attributable to a change in V max , not K m . The V max for xanthine:xanthine-oxidase-treated cells (5877 pmole/mg per 15 min) was decreased 10% compared with control cells (6579 pmole/mg per 15 min; P<0.001). The K m for both xanthine:xanthine-oxidase-treated and control cells were similar, viz., 19.23 and 18.9 μM, respectively, and were within the range reported for GLAST K m (11-77 μM; Anderson and Swanson 2000) . Kinetic analysis showed that the increase in system x c − activity was also attributable to a change in V max , not K m . For system x c − , the V max for xanthine:xanthine-oxidase-treated cells (1946 pmole/mg per 15 min) was 30% higher than the V max (1459 pmole/mg per 15 min) calculated for control cells (P<0.0002). The K m s for both xanthine:xanthineoxidase-treated and control cells were similar, viz., 57.3 and 54.9 μM, respectively, which were values in the range of those published for other retinal cell types (Bridges et al. 2004; Dun et al. 2006) .
Analysis of gene expression in Müller cells treated with 70:14 xanthine:xanthine oxidase for 6 h showed a marked increase in the expression of mRNA encoding xCT. Representative gels of these experiments are shown in Fig. 6a . Whereas the level of the 315-bp 18S (internal standard) was the same for control and xanthine:xanthineoxidase-treated cells, the level of the 181-bp xCT was much greater in cells exposed to oxidative stress compared with controls. Densitometric analysis confirmed that xCT mRNA was elevated significantly (2.4-fold) relative to controls (P<0.0005; Fig. 6b ). This elevation in xCT gene expression was consistent with the increase in system x c − transporter activity observed in uptake studies (Figs. 4, 5) . There was no significant change in GLAST or 4F2hc mRNA under these oxidative stress conditions.
Although xCT has a predicted molecular mass of 55 kDa, two size variants of xCT (35-40 kDa and 50-55 kDa) have been reported (Tomi et al. 2003) . To determine which form of xCT (50 kDa or 40 kDa) was altered under oxidative stress, Müller cells were treated for 6 h with 70:14 xanthine:xanthine oxidase, and biotinylation techniques were used to separate plasma membrane proteins from intracellular proteins. Western blot analysis of the fractions showed that the predominant form of xCT isolated from Müller cells had a molecular weight of~50 kDa; there was no detectable change in the level of this form of xCT (as a consequence of oxidative stress). In controls, the 40 kDa form is located almost exclusively in the intracellular fraction, whereas, under oxidative stress conditions, the 40-kDa form shifts its location and is elevated. As shown in Fig. 7a, b , the 40-kDa form of xCT located in the plasma membrane of the xanthine:xanthineoxidase-treated cells was 3.6-fold greater than in controls. These data suggest that the elevation of the 40-kDa form of xCT present on the plasma membrane of xanthine:xanthineoxidase-treated Müller cells accounts for the increased system x c − activity observed in uptake experiments. 
Discussion
The experiments undertaken in this study were designed to test the effects of hyperglycemia and oxidative stress (two factors associated with diabetes) on the activity of glutamate transporters present in retinal Müller cells. GLAST is a well-characterized sodium-dependent glutamate transporter responsible for clearing excess glutamate from the extracellular milieu. System x c − is a sodium-independent cysteine-glutamate exchanger that plays a key role in the generation of the antioxidant glutathione. Given reports that glutamate in the retina and vitreous of diabetic subjects is elevated, that excessive levels of extracellular glutamate are toxic to retinal neurons, and that neuronal alterations are evident in diabetic retinopathy, we considered it likely that glutamate clearance from the extracellular milieu would be impaired in the retina of diabetic subjects.
This was also the premise of the studies by Li and Puro (2002) who isolated Müller cells from diabetic rat retinas and demonstrated a profound decrease in the activity of the GLAST transporter by using an indirect assessment of function. They applied electrophysiological methods to assess the inward current induced by PDC and found a 67% decrease in transporter function. Their findings were intriguing and prompted us to investigate whether the effects on GLAST activity could be compromised solely by hyperglycemia. Our laboratory has extensive experience in analyzing the function of transporter proteins in cultured cells by directly assessing the uptake of radiolabeled substrates, such as glutamate. The experimental system is attractive because it permits the testing of a single factor Fig. 5 Kinetic analysis of GLAST and system x c − in cells exposed to oxidative stress. Mouse Müller cells were treated for 6 h with 70:14 xanthine:xanthine oxidase (X:XO), following which the uptake of [ 3 H]-glutamate by Na + -dependent GLAST (a) and Na + -independent system x c − (b) were assessed by using increasing amounts of nonradioactive glutamate ranging from 2.5 μM to 500 μM. The rate of glutamate uptake (pmole/mg per 15 min) is shown as a function of glutamate concentration (µM). Insets: Eadie-Hofstee plots of V, uptake velocity (pmole/mg per 15 min) versus V/S where S is non-radioactive glutamate concentration (µM). Values presented are means ± SE from two independent experiments performed in triplicate Fig. 4 Effect of oxidative stress on GLAST and system x c − activity. Mouse Müller cells were treated for 6 h in the absence or presence of increasing levels of xanthine:xanthine oxidase as a source of superoxide anions, following which the uptake of [ 3 H] glutamate was measured in the presence or absence of sodium (Na + ). Concentrations of xanthine:xanthine oxidase (in μM:mU/ml) were: 10:2, 40:8, 70:14 and 100:20. Glutamate uptake by the Na + -dependent GLAST transporter (a) or the Na + -independent system x c − (b). Values presented are means ± SE from two to three independent experiments performed in triplicate. **P<0.005, ***P<0.0005; significantly different from control (such as hyperglycemia) independent of other factors that might be present in a complex disease such as diabetes; the present experiments involved the use of Müller cells isolated from the mouse retina. Our immunohistochemical data showed that GLAST transporter was present in these cells. Interestingly, exposure of the cells to hyperglycemia did not impair GLAST function as anticipated. We examined GLAST transporter function over a time course (15 min to 8 days) and found that neither very short periods of hyperglycemia nor longer exposure altered the uptake of radiolabeled glutamate. Gene expression was not affected, nor was the protein level until cells had been exposed for 8 days to 35 mM glucose, when there was actually a detectable increase in GLAST protein levels. The results of our studies suggest that hyperglycemia alone is insufficient to impair GLAST function (at least short term) in retinal Müller cells.
Our experimental paradigm has allowed the analysis of system x c − , a second system mediating cellular glutamate levels. The protein constituents of system x c − (xCT and 4F2hc) are colocalized in mouse Müller cells. This cystineglutamate exchanger operates bi-directionally either taking glutamate into or out of cells in exchange for cystine. Typically, it operates to take cystine into the cell for the synthesis of glutathione, a key antioxidant in the retina; however, its function can be assessed by using radiolabeled glutamate as the substrate. The use of sodium-containing buffer versus buffer lacking sodium enables the function of GLAST to be distinguished from that of system x c − .
Analysis of system x c − activity in Müller cells exposed to hyperglycemia has revealed no change in activity over the course of the experimental time period. Intriguingly, hyperglycemia is not sufficient to disrupt the function of either GLAST or system x c − in cultured mouse Müller cells. Hyperglycemia is often viewed as the single most important factor involved in the onset and progression of diabetic retinopathy (Diabetes Control and Complications Trial Research Group 1993, 1996; Genuth 2006) . Many reports exist regarding the effects of elevated glucose on several different retinal cell types, e.g., the increased apoptosis in Müller cells and pericytes cultured in high glucose (Beltramo et al. 2006; Du et al. 2003; Kusner et al. 2004) . Elevated glucose compromises the function of other transporter proteins, including the reducedfolate transporter of RPE cells (Naggar et al. 2002) . Exposure of RPE cells to 45 mM glucose for as short an incubation time as 6 h results in a 35% decrease in the uptake of folate. This decreased activity is accompanied by decreased gene and protein expression for the folate transporter protein. The data obtained herein suggest that Müller cells can sustain GLAST and system x c − function under hyperglycemic conditions, at least when challenged for a short period of time with this stressful condition. Oxidative stress is well known to be associated with diabetes. In diabetes, oxidative stress is induced by the overproduction of superoxide by the mitochondrial electron transport chain (Nishikawa et al. 2000) . Increased superoxide concentration is considered a major causative factor in the pathogenesis of diabetic complications (Kowluru and Chan 2007) . In the study by Li and Puro (2002) mentioned above, the mechanism responsible for decreased GLAST function in diabetes has been suggested to be oxidative in nature, because disulfide DTT, a disulfide-reducing agent, restores GLAST transporter activity.
In the present study, we have analyzed whether oxidative stress can alter GLAST activity and that of system x c − . Indeed, this is this first report of an analysis of the effects of oxidative stress on the function of the two transporters (GLAST and system x c − ) in parallel. Oxidative stress has been induced in cultures of Müller cells by using a combined application of xanthine:xanthine oxidase, a wellknown method for generating superoxide and hydrogen peroxide in a molar ratio of approximately 1:3 (Asai et al. 2007) . When the effects of xanthine:xanthine oxidase on GLAST and system x c − function were assessed, the most remarkable effect was on system x c − function, not on GLAST. Exposure of cells to xanthine:xanthine oxidase decreased GLAST activity, albeit slightly (10%), but increased system x c − activity by 40%-80%, depending upon the xanthine:xanthine oxidase concentration. The kinetic analysis indicated that the increased activity was attributable to a change in V max , not K m . Subsequent molecular analysis of system x c − showed that oxidative stress increased the expression of the mRNA encoding xCT. Analysis of plasma membrane and intracellular fractions revealed that the 40-kDa-sized form of xCT was substantially elevated on the plasma membrane as a function of xanthine:xanthine oxidase treatment, whereas the 50-kDa-sized form of xCT was unchanged in level or site of expression. Whereas our lab and others have shown increased system x c − activity in various cell types exposed to oxidative-stress-inducing agents such as H 2 O 2 , NO donors, superoxide anion, elevated O 2 , and the electrophilic agent diethyl maleate (Bannai et al. 1989; Kim et al. 2001; Bridges et al. 2001; Dun et al. 2006; Tomi et al. 2003) , these data are, to our knowledge, the first to demonstrate (1) the relative expression of xCT inside the cell compared with the plasma membrane and (2) a change in isoform distribution as a response to cellular stress. Interestingly, even though the most predominant form of xCT is the 50-kDa form, the 40-kDa form is the one that, under oxidative stress, increases and shifts its location from intracellular to the plasma membrane. This raises intriguing questions about the function of the 50-kDa form with respect to function in system x c − .
Although not the focus of this study, future investigations of this transporter might include an analysis of the function of the 50-kDa isoform, whether it is involved in transport activity, and if so, whether the activity is regulated by post-translational modifications such as phosphorylation or glycosylation.
Based on the findings of Li and Puro (2002) suggesting that oxidative damage accounted for the decreased activity of GLAST in isolated Müller cells, we were surprised to observe a modest effect of oxidative stress on GLAST activity, especially when compared with the robust effect on the cystine-glutamate exchanger. The system employed by Li and Puro (2002) allowed only the indirect assessment of GLAST transporter activity but was attractive in that cells were isolated from rats that had been diabetic for many weeks. Our system permits the direct assessment of GLAST activity and has enabled us to assess the effects of a single factor (oxidative stress), but in isolated cultured glial cells. Our attempts to isolate Müller cells from the retinas of diabetic animals have not been successful because of the decreased viability of cells isolated from older animals.
The upregulation of xCT and increase in system x c − activity observed in this study are presumably beneficial because this transporter is integral to the production of the antioxidant glutathione, which protects cells from stress. The increase in system x c − activity may be relevant to the findings of Ward et al. (2005) who have shown a slight, but insignificant, increase (not decrease) in GLAST activity and expression in diabetic rat retinas; they have interpreted their data as indicating that, although Müller cells undergo gliosis in early stages of diabetic retinopathy, they preserve the function of GLAST. The analysis of transporter protein function is frequently performed in cell lines. To approximate Müller cell transporter activity in vivo more closely, we have isolated the cells from young mouse retinas and have passaged them approximately three times to produce sufficient numbers of cells for an assessment of transport function. The cells retain Müller cell marker proteins. The advantages of such a system include the ability to pose experimental questions regarding the effects of specific factors on transport function in a single cell type, rather than myriad effects on a mixture of cell types (such as an isolated whole retinal preparation). A caveat in the interpretation of data derived from this experimental system, however, is that the analysis is devoid of the cellular and biological milieu characteristic of complex physiological systems. Factors that are associated with disease, e.g., the altered blood flow, vascular changes, edema, and inflammation involved in diabetes, are not reflected in the experimental paradigm used in the present studies. Even with these limitations, the data obtained provide intriguing findings regarding two factors commonly associated with diabetes: hyperglycemia and oxidative stress. The data suggest that glutamate uptake by GLAST and system x c − in isolated Müller cells is not profoundly affected by hyperglycemia alone, and that GLAST activity is not as susceptible to oxidative stress in isolated Müller cells as is system x c − . To our knowledge, this work represents the first analysis of both of these proteins in experiments intended to mimic conditions associated with diabetes.
We should also mention that, whereas GLAST plays a key role in the Na + -dependent transport of glutamate in Müller cells and is therefore a logical transporter to study with respect to effects of cellular stress, Sarthy et al. (2005) have reported that new, as yet unidentified, Na + -dependent, high-affinity glutamate transporters might be present in Müller cells. As the molecular characterization of such transporters unfolds, the determination of their expression levels and sensitivity to cellular stress should be highly informative. Interestingly, although Na + -independent uptake of glutamate can occur via the AGT1 transporter in some systems, there is no evidence for the expression of this transporter in the retina (Sarthy et al. 2005) . Thus, system x c − is the only known transporter for glutamate in
Müller cells under sodium-free conditions.
